Frontiers in Cellular and Infection Microbiology

(The H4-Index of Frontiers in Cellular and Infection Microbiology is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development461
The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks318
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus288
Antibiotics as Major Disruptors of Gut Microbiota273
ACE2, Much More Than Just a Receptor for SARS-COV-2241
How Probiotics Affect the Microbiota211
Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices200
Microglial Cells: The Main HIV-1 Reservoir in the Brain194
Fecal Microbiota Transplantation in Neurological Disorders188
ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis)177
Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)174
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields163
The Oral Microbiota May Have Influence on Oral Cancer155
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China146
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)145
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens139
Role and Mechanism of Gut Microbiota in Human Disease131
SARS-COV-2 Variants: Differences and Potential of Immune Evasion126
Antibiotic Resistance: One Health One World Outlook122
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance121
Antifungal Peptides as Therapeutic Agents116
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence105
Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets102
The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease100
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey98
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression98
The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders97
Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response97
Wuhan to World: The COVID-19 Pandemic95
Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China93
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System93
Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential92
Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan92
Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of CO91
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species90
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine82
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics82
Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders81
The Female Vaginal Microbiome in Health and Bacterial Vaginosis81
Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis78
An Update on Molecular Diagnostics for COVID-1978
A Novel Scoring System for Prediction of Disease Severity in COVID-1978
Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs78
Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives76
Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans76
Urinary Microbiome: Yin and Yang of the Urinary Tract76
Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia76
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities74
Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment73
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease73
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro72
Gut Microbiota Status in COVID-19: An Unrecognized Player?72
Chitosan-Based Nanoparticles Against Viral Infections72
Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Encephalitis and Meningitis: A Large, Prospective Case Series of 213 Patients71
Periodontal Disease: The Good, The Bad, and The Unknown69
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria68
Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions67
Promising Therapeutic Strategies Against Microbial Biofilm Challenges67
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection67
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome66
Clinical Evaluation of Diagnosis Efficacy of Active Mycobacterium tuberculosis Complex Infection via Metagenomic Next-Generation Sequencing of Direct Clinical Samples66
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases66
Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis65
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review64